Prezalumab Biosimilar - Research Grade

Human

B7H2

5mg/ml

Human IgG2 (S378A)-Kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects B7H2

Blue ice

B7-H2 (ICOSLG) is a co-stimulatory ligand that engages ICOS to shape T-cell help, of interest across immunology and autoimmune research. Supplied as an unconjugated, non-therapeutic analog of prezalumab, this recombinant anti-human B7H2 antibody is for research use only (RUO). It is manufactured to in vivo standards, presents low endotoxin, and is available in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. The reagent supports functional assays, co-stimulation-blockade and T-cell studies, reproducible controls, and in vivo models of immune regulation, delivering dependable lot-to-lot consistency for high-volume immunology programmes.

inducible T-cell co-stimulator ligand, B7H2, B7-H2, ICOS-L, B7-related protein 1, B7RP1, B7RP-1, B7 homolog 2, B7 homologue 2, GL50, KIAA0653, CD275

O75144

ICH3002

https://www.imgt.org/mAb-DB/